Both mutants were also enriched for FLT3, and AML associated signaling pathways such as ERK/MAPK, JAK/STAT, mTOR, and PI3K/AKT, although with less power (Additional file 2: Table S12). This evidence concerns the gene MTOR and acute myeloid leukemia.